Chula Vista, CANCT07675590Now EnrollingIRB Ready

Health Adult Subjects Clinical Trial in Chula Vista, CA

Access cutting-edge health adult subjects treatment through this phase 1 clinical trial at a research site in Chula Vista. Study-provided care at no cost to qualified participants.

Sponsored by TIXiMED, Inc.

Quick Self-Assessment

See if you qualify for this Chula Vista location

Preparing your pre-screening questions…

Expert Care in Chula Vista

Access health adult subjects specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related health adult subjects treatment provided free

Apply for This Chula Vista Location

Check if you qualify for this health adult subjects clinical trial in Chula Vista, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Chula Vista

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Chula Vista site if eligible
  4. 4Begin participation

About This Health Adult Subjects Study in Chula Vista

Randomized, Placebo-controlled Study to determine the safety and tolerability of multiple oral doses of TIX100 administered daily for 28 days to otherwise healthy overweight/obese subjects.

Sponsor: TIXiMED, Inc.

Who Can Participate

Inclusion Criteria

Subjects aged 18-70 years, both genders.
Healthy as determined by the Investigator, based on history, medical examination, vital signs, laboratory tests, cardiac monitoring and respiratory function. History must comply with the following:
Absence of clinically significant illness or surgery within the preceding 12 weeks.
Absence of clinically significant history of neurological, endocrine, cardiovascular, pulmonary, hematological, immunologic, psychiatric, gastrointestinal, renal, hepatic, and/or metabolic disease.
Male subjects with female partners of childbearing potential must agree to utilize condoms for the duration of the study.
Female subjects of child-bearing potential with negative urine pregnancy tests and who agree to use double-barrier contraception during the study. The primary contraception may be oral contraceptives, hormonal implant or hormonal or non-hormonal intrauterine device, and the secondary (barrier) method of contraception with condom and/or with spermicide.
Female subjects of non-child-bearing potential (i.e. bilateral tubal ligation (BTL), bilateral tubal occlusion (BTO), bilateral salpingectomy, hysterectomy, partial hysterectomy, bilateral oophorectomy, or postmenopausal, defined as no menses for 12 months without an alternative medical cause).
Body mass index (BMI) 25 - 34.9 kg/m2
HbA1c \<6.5%
Willingness to fully comply with protocol.

Exclusion Criteria

History of excessive alcohol use (defined as \>21 drinks per week for males and \>14 drinks per week for females), recreational drug use or drugs of abuse within the past three months, or failure on urinary drug screen.
Pregnant or breastfeeding within six months of screening assessment.
Substantial changes in eating habits or exercise routines within the preceding three months.
Evidence of eating disorders.
\>5% weight change in the past three months.
Bariatric surgery within the past five years.
Significant renal impairment (eGFR \<60 mL/min/1.73m2).
Liver function tests (i.e., ALT, AST, alkaline phosphatase) greater than twice the upper limit of normal upon repeated measurements.
Diseases interfering with metabolism and/or ingestive behavior (e.g., myxedema, Cushing's disease, schizophrenia, major psychoses, unmanaged depression).
Use of prescription medications during screening and duration of the trial.
Use of drugs approved for the treatment of obesity.
Any clinically significant abnormality following the Investigator's review of the physical examination and clinical laboratory tests.
A baseline prolongation of QT/QTcF interval after repeated measurements of \>450 ms for men and \>470 for women; a history of unexplained syncope, cardiac arrest, unexplained cardiac arrhythmias or torsades de pointes, structural heart disease, or a family history of LQTS.
Participation in an investigational drug trial within three months prior to dosing in the present study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chula Vista?

Yes, this clinical trial (NCT07675590) has an active research site in Chula Vista, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Health Adult Subjects Treatment Options in Chula Vista, CA

If you're searching for health adult subjects treatment options in Chula Vista, CA, this clinical trial (NCT07675590) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chula Vista research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced health adult subjects specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all health adult subjects clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in Chula Vista, CA

See all alzheimers disease clinical trials recruiting in Chula Vista — not just this study.

Browse Alzheimers Disease Trials in Chula Vista →

Browse More Trials by Condition

Alzheimers Disease TrialsAtopic Dermatitis TrialsCarpal Tunnel TrialsAll Conditions →

Ready to Join in Chula Vista?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Chula Vista, CA